Initiate Novel Diabesity drug targets discovery and validation based franchise objective (targeting Islets and via incretins gut hormones as secretagogues and Inflammation induce insulin resistance, panreatic beta cells dysfunction and NALFD/NASH).
Utilize Human whole blood or isolated monocytes/macrophages/islets/adipocytes to assess pharmacology for confidence and rationale associated with inflammation
Reviews and evaluates drug targets, opportunities and potential strategies for early and late stage drug development across a wide range of therapeutic areas.
Investigate animal models to address Efficacy, Safety, Toxicology and PK/PD in a preclinical R&D.
Engineered and d...